Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

Objectives: Antidepressant drugs are used frequently during pregnancy. The risk assessment of SSRI exposure is still evaluated and re-opened due to studies indicating possible increase of inborn defects, neonatal abstinence syndrome and cognitive ability or behavioral defects.

Methods: In our study, we prospectively followed groups of pregnancies in years 2002-2009, that were exposed to SSRI.

Embryotoxicity of mirtazapine: a study using Chick Embryotoxicity Screening Test.

Objective: Mirtazapine is a new antidepressant used in last years, however experience with it during pregnancy is unsatisfactory on the present. Its wide therapeutic range and only little proved side effects may be an advantage for treatment during pregnancy. Aim of our study was to contribute to the knowledge on possible risks.